Concurrent with the epidemiological transition to cardiovascular diseases in low-and middle-
income countries (LMICs), the burden of arrhythmias is increasing significantly. However …

Background Knowledge about oral anticoagulant treatment can impact treatment outcomes
in patients with atrial fibrillation. However, evidence is scarce regarding the knowledge of …

Anticoagulation management using warfarin is challenging in clinical practice. This study
aimed to evaluate the knowledge, adherence, and satisfaction with warfarin therapy and …

Background Cardiovascular diseases are one of the major causes of mortality at the global
level. They account for approximately 17.9 million deaths per year. Warfarin and …

Background Intracerebral hemorrhage (ICH) affects up to 1% of chronic oral anticoagulation
(OAC) users per year. This study explored the knowledge, attitude and practice (KAP) …

Objective: Oral anticoagulant drugs, such as warfarin, are widely used for preventing and
treating vascular and thromboembolic disease in patients with chronic atrial fibrillation …

Objective To develop and validate an oral anticoagulant knowledge tool for Chinese-
speaking patients treated with warfarin or direct oral anticoagulants (DOACs) in Hong Kong …

The advent of direct-acting oral anticoagulants (DOACs) has largely replaced warfarin, a
vitamin K antagonist, as a therapy of choice for the prevention and management of …

The descriptive, cross-sectional study was planned to assess patients' knowledge on
warfarin usage at a newlydeveloped health facility in Quetta, Pakistan. Warfarin knowledge …

Venous thromboembolism (VTE) is a significant cardiovascular disease with a relatively high
incidence rate, presenting a significant clinical burden. Its effective diagnosis and treatment …